COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand, Martin Scholz, Vladimir Zelenko
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106214
The aim of this study was to describe the outcomes of patients with coronavirus disease 2019 in the outpatient setting after early treatment with zinc, low-dose hydroxychloroquine and azithromycin (triple therapy) dependent on risk stratification. This was a retrospective case series study in the general practice setting. A total of 141 COVID-19 patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the year 2020 were included. The main outcome measures were risk-stratified treatment decision and rates of hospitalisation and all-cause death. A median of 4 days [interquartile range (IQR) 3-6 days; available for n = 66/141 patients] after the onset of symptoms, 141 patients (median age 58 years, IQR 40-67 years; 73.0% male) received a prescription for triple therapy for 5 days. Independent public reference data from 377 confirmed COVID-19 patients in the same community were used as untreated controls. Of 141 treated patients, 4 (2.8%) were hospitalised, which was significantly fewer ( P < 0.001) compared with 58 (15.4%) of 377 untreated patients [odds ratio (OR) = 0.16, 95% confidence interval (CI) 0.06-0.5]. One patient (0.7%) in the treatment group died versus 13 patients (3.4%) in the untreated group (OR = 0.2, 95% CI 0.03-1.5; P = 0.12). No cardiac side effects were observed. Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset using triple therapy, including the combination of zinc with low-dose hydroxychloroquine, was associated with significantly fewer hospitalisations.
Competing interests RD is/was at the time of writing an employee of Alexion Pharma Germany GmbH, and his engagement and contribution to this study and publication was private and independent from his employer; MS is/was at the time of writing External Senior Advisor for the company LEUKOCARE (Munich, Germany) and is/was Manging Director at Starts-and -Ups Consulting (Frankfurt, Germany); VZ is/was a general practitioner in New York State (USA).
Ethical approval This study was approved by the Western Institutional Review Board and was exempt under 45 CFR § 46.104(d)(4). Ref. Number: D4-Excemption-Zelenko (06-16-2020).
References
Anderson, Roussel, Zouari, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J Am Coll Nutr,
doi:10.1080/07315724.2001.10719034
Andreani, Bideau, Duflot, In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect, Microb Pathog,
doi:10.1016/j.micpath.2020.104228
Atri, Siddiqi, Lang, COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies, JACC Basic Transl Sci,
doi:10.1016/j.jacbts.2020.04.002
Boulware, Pullen, Bangdiwala, A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19, N Engl J Med,
doi:10.1056/NEJMoa2016638
Braun, Rosenfeldt, Pharmaco-nutrient interactions-a systematic review of zinc and antihypertensive therapy, Int J Clin Pract,
doi:10.1111/ijcp.12040
Carlucci, Ahuja, Petrilli, Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients, medRxiv,
doi:10.1101/2020.05.02.20080036
Chen, Wu, Chen, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ,
doi:10.1136/bmj.m1091
Coutard, Valle, De Lamballerie, The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral Res,
doi:10.1016/j.antiviral.2020.104742
Derwand, Scholz, Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?, Med Hypotheses,
doi:10.1016/j.mehy.2020.109815
Ervin, Kennedy-Stephenson, Mineral intakes of elderly adult supplement and non-supplement users in the third National Health and Nutrition Examination Survey, J Nutr,
doi:10.1093/jn/132.11.3422
Esper, Da Silva, Oikawa, Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine
Fry, Goswami, Nahar, Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial, Lancet Infect Dis,
doi:10.1016/s1473-3099(13)70267-6
Gautret, Lagier, Parola, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.105949
Geleris, Sun, Platt, Observational study of hydroxychloroquine in hospitalized patients with COVID-19, N Engl J Med,
doi:10.1056/NEJMoa2012410
Ghaly, Knezevic, What happened to 'patient first' and 'do no harm' medical principles?, Surg Neurol Int,
doi:10.4103/sni.sni_447_17
Giacomelli, Pezzati, Conti, Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study, Clin Infect Dis,
doi:10.1093/cid/ciaa330
Gordon, Amissah-Arthur, Gayed, The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults, Rheumatology,
doi:10.1093/rheumatology/kex286
Gupta, Real-world clinical effectiveness and tolerability of hydroxychloroquine 400 mg in uncontrolled type 2 diabetes subjects who are not willing to initiate insulin therapy (HYQ-Real-World Study), Curr Diabetes Rev,
doi:10.2174/1573399815666190425182008
Johnson, Rigge, Culliford, Primary care risk stratification in COPD using routinely collected data: a secondary data analysis, NPJ Prim Care Respir Med,
doi:10.1038/s41533-019-0154-6
Kane, Hydroxychloroquine sulfate. Drug usage statistics
Lane, Weaver, Kostka, Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study, medRxiv,
doi:10.1101/2020.04.08.20054551
Liu, Cao, Xu, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov,
doi:10.1038/s41421-020-0156-0
Lovato, De Filippis, Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms, Ear Nose Throat J,
doi:10.1177/0145561320920762
Mahevas, Tran, Roumier, No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial, medRxiv,
doi:10.1101/2020.04.10.20060699
Mehra, Ruschitzka, Patel, Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet,
doi:10.1016/S0140-6736(20)31324-6
Mercer, Rekedal, Garg, Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals, Arthritis Res Ther,
doi:10.1186/ar3868
Millet, Whittaker, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein, Proc Natl Acad Sci U S A,
doi:10.1073/pnas.1407087111
Million, Gautret, Colson, Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world, New Microbes New Infect,
doi:10.1016/j.nmni.2020.100709
Million, Lagier, Gautret, Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France, Travel Med Infect Dis,
doi:10.1016/j.tmaid.2020.101738
Onder, Rezza, Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA,
doi:10.1001/jama.2020.4683
Pareek, Chandurkar, Thomas, Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone, Curr Med Res Opin,
doi:10.1185/03007995.2014.909393
Prasad, Beck, Bao, Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress, Am J Clin Nutr,
doi:10.1093/ajcn/85.3.837
Richardson, Hirsch, Narasimhan, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA,
doi:10.1001/jama.2020.6775
Risch, Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped-up immediately as key to the pandemic crisis, Am J Epidemiol,
doi:10.1093/aje/kwaa093
Shiryaev, Remacle, Ratnikov, Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens, J Biol Chem,
doi:10.1074/jbc.M703847200
Siddiqi, Mehra, COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal, J Heart Lung Transplant,
doi:10.1016/j.healun.2020.03.012
Siemieniuk, Bartoszko, Ge, Drug treatments for COVID-19: living systematic review and network meta-analysis, BMJ,
doi:10.1136/bmj.m2980
Stawowy, Kallisch, Pereira Stawowy, Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis, Virchows Arch,
doi:10.1007/s00428-004-1198-7
Tang, Cao, Han, Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial, medRxiv,
doi:10.1101/2020.04.10.20060558
Van Den Akker, Buntinx, Metsemakers, Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases, J Clin Epidemiol,
doi:10.1016/s0895-4356(97)00306-5
Velthuis, Van Den Worm, Sims, Zn 2 + inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS Pathog,
doi:10.1371/journal.ppat.1001176
Wallace, The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review, Lupus
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA,
doi:10.1001/jama.2020.1585
Yang, Shen, Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19, Int J Biol Sci,
doi:10.7150/ijbs.45498
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis,
doi:10.1093/cid/ciaa237
Yu, Li, Chen, Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19, Sci China Life Sci,
doi:10.1007/s11427-020-1732-2
Zarychanski, Stuart, Kumar, Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection, CMAJ,
doi:10.1503/cmaj.091884
Zou, Ruan, Huang, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med,
doi:10.1056/NEJMc2001737
DOI record:
{
"DOI": "10.1016/j.ijantimicag.2020.106214",
"ISSN": [
"0924-8579"
],
"URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.106214",
"alternative-id": [
"S0924857920304258"
],
"article-number": "106214",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "International Journal of Antimicrobial Agents"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ijantimicag.2020.106214"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 The Author(s). Published by Elsevier Ltd."
}
],
"author": [
{
"affiliation": [],
"family": "Derwand",
"given": "Roland",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-7009-9988",
"affiliation": [],
"authenticated-orcid": false,
"family": "Scholz",
"given": "Martin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Zelenko",
"given": "Vladimir",
"sequence": "additional"
}
],
"container-title": "International Journal of Antimicrobial Agents",
"container-title-short": "International Journal of Antimicrobial Agents",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"clinicalkey.fr",
"clinicalkey.jp",
"clinicalkey.es",
"clinicalkey.com.au",
"clinicalkey.com",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
10,
26
]
],
"date-time": "2020-10-26T16:42:42Z",
"timestamp": 1603730562000
},
"deposited": {
"date-parts": [
[
2022,
7,
3
]
],
"date-time": "2022-07-03T15:57:44Z",
"timestamp": 1656863864000
},
"indexed": {
"date-parts": [
[
2024,
3,
1
]
],
"date-time": "2024-03-01T07:06:16Z",
"timestamp": 1709276776168
},
"is-referenced-by-count": 79,
"issue": "6",
"issued": {
"date-parts": [
[
2020,
12
]
]
},
"journal-issue": {
"issue": "6",
"published-print": {
"date-parts": [
[
2020,
12
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
10,
25
]
],
"date-time": "2020-10-25T00:00:00Z",
"timestamp": 1603584000000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920304258?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920304258?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "106214",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
12
]
]
},
"published-print": {
"date-parts": [
[
2020,
12
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.ijid.2020.03.004",
"article-title": "The SARS-CoV-2 outbreak: what we know",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "44",
"journal-title": "Int J Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0001",
"volume": "94",
"year": "2020"
},
{
"DOI": "10.1016/j.jacbts.2020.04.002",
"article-title": "COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies",
"author": "Atri",
"doi-asserted-by": "crossref",
"first-page": "518",
"journal-title": "JACC Basic Transl Sci",
"key": "10.1016/j.ijantimicag.2020.106214_bib0002",
"volume": "5",
"year": "2020"
},
{
"article-title": "Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient cases",
"author": "Prieto-Alhambra",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0003",
"volume": "8",
"year": "2020"
},
{
"DOI": "10.1016/S0196-0644(89)80213-6",
"article-title": "Analysis of emergency department management of suspected bacterial meningitis",
"author": "Talan",
"doi-asserted-by": "crossref",
"first-page": "856",
"journal-title": "Ann Emerg Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0004",
"volume": "18",
"year": "1989"
},
{
"article-title": "Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load",
"author": "Gonçalves",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0005",
"year": "2020"
},
{
"DOI": "10.1016/j.healun.2020.03.012",
"article-title": "COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal",
"author": "Siddiqi",
"doi-asserted-by": "crossref",
"first-page": "405",
"journal-title": "J Heart Lung Transplant",
"key": "10.1016/j.ijantimicag.2020.106214_bib0006",
"volume": "39",
"year": "2020"
},
{
"DOI": "10.1016/S1473-3099(13)70267-6",
"article-title": "Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial",
"author": "Fry",
"doi-asserted-by": "crossref",
"first-page": "109",
"journal-title": "Lancet Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0007",
"volume": "14",
"year": "2014"
},
{
"DOI": "10.1016/j.tmaid.2020.101658",
"article-title": "Repurposing antimalarials and other drugs for COVID-19",
"author": "Schlagenhauf",
"doi-asserted-by": "crossref",
"journal-title": "Travel Med Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0008",
"volume": "34",
"year": "2020"
},
{
"DOI": "10.1177/0961203396005001131",
"article-title": "The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review",
"author": "Wallace",
"doi-asserted-by": "crossref",
"first-page": "S59",
"issue": "Suppl 1",
"journal-title": "Lupus",
"key": "10.1016/j.ijantimicag.2020.106214_bib0009",
"volume": "5",
"year": "1996"
},
{
"DOI": "10.1093/rheumatology/kex286",
"article-title": "The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults",
"author": "Gordon",
"doi-asserted-by": "crossref",
"first-page": "e1",
"journal-title": "Rheumatology (Oxford)",
"key": "10.1016/j.ijantimicag.2020.106214_bib0010",
"volume": "57",
"year": "2018"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0011",
"series-title": "Model list of essential medicines",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0012",
"unstructured": "Kane S.P.Hydroxychloroquine sulfate. Drug usage statistics, United States, 2007–2017. ClinCalc DrugStats Database, Version 20.1.https://clincalc.com/DrugStats/Drugs/HydroxychloroquineSulfate [accessed 23 May 2020]."
},
{
"DOI": "10.1016/j.ijantimicag.2020.105949",
"article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
"author": "Gautret",
"doi-asserted-by": "crossref",
"journal-title": "Int J Antimicrob Agents",
"key": "10.1016/j.ijantimicag.2020.106214_bib0013",
"volume": "56",
"year": "2020"
},
{
"article-title": "Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial",
"author": "Tang",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0014",
"year": "2020"
},
{
"article-title": "A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19",
"author": "Chen",
"first-page": "215",
"journal-title": "Zhejiang Da Xue Xue Bao Yi Xue Ban",
"key": "10.1016/j.ijantimicag.2020.106214_bib0015",
"volume": "49",
"year": "2020"
},
{
"article-title": "No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial",
"author": "Mahevas",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0016",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31324-6",
"article-title": "Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis",
"author": "Mehra",
"doi-asserted-by": "crossref",
"first-page": "1820",
"journal-title": "Lancet",
"key": "10.1016/j.ijantimicag.2020.106214_bib0017",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31290-3",
"article-title": "Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis",
"doi-asserted-by": "crossref",
"first-page": "E102",
"journal-title": "Lancet",
"key": "10.1016/j.ijantimicag.2020.106214_bib0018",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.7150/ijbs.45498",
"article-title": "Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19",
"author": "Yang",
"doi-asserted-by": "crossref",
"first-page": "1724",
"journal-title": "Int J Biol Sci",
"key": "10.1016/j.ijantimicag.2020.106214_bib0019",
"volume": "16",
"year": "2020"
},
{
"DOI": "10.1371/journal.pone.0109180",
"article-title": "Chloroquine is a zinc ionophore",
"author": "Xue",
"doi-asserted-by": "crossref",
"journal-title": "PLoS One",
"key": "10.1016/j.ijantimicag.2020.106214_bib0020",
"volume": "9",
"year": "2014"
},
{
"DOI": "10.1371/journal.ppat.1001176",
"article-title": "Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture",
"author": "te Velthuis",
"doi-asserted-by": "crossref",
"journal-title": "PLoS Pathog",
"key": "10.1016/j.ijantimicag.2020.106214_bib0021",
"volume": "6",
"year": "2010"
},
{
"DOI": "10.1016/j.mehy.2020.109815",
"article-title": "Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?",
"author": "Derwand",
"doi-asserted-by": "crossref",
"journal-title": "Med Hypotheses",
"key": "10.1016/j.ijantimicag.2020.106214_bib0022",
"volume": "142",
"year": "2020"
},
{
"article-title": "Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients",
"author": "Carlucci",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0023",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m2980",
"article-title": "Drug treatments for COVID-19: living systematic review and network meta-analysis",
"author": "Siemieniuk",
"doi-asserted-by": "crossref",
"first-page": "m2980",
"journal-title": "BMJ",
"key": "10.1016/j.ijantimicag.2020.106214_bib0024",
"volume": "370",
"year": "2020"
},
{
"DOI": "10.1016/j.nmni.2020.100709",
"article-title": "Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world",
"author": "Million",
"doi-asserted-by": "crossref",
"journal-title": "New Microbes New Infect",
"key": "10.1016/j.ijantimicag.2020.106214_bib0025",
"volume": "38",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2016638",
"article-title": "A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19",
"author": "Boulware",
"doi-asserted-by": "crossref",
"first-page": "517",
"journal-title": "N Engl J Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0026",
"volume": "383",
"year": "2020"
},
{
"DOI": "10.1016/S1473-3099(20)30113-4",
"article-title": "Viral load of SARS-CoV-2 in clinical samples",
"author": "Pan",
"doi-asserted-by": "crossref",
"first-page": "411",
"journal-title": "Lancet Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0027",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.3346/jkms.2020.35.e86",
"article-title": "Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea",
"author": "Kim",
"doi-asserted-by": "crossref",
"first-page": "e86",
"journal-title": "J Korean Med Sci",
"key": "10.1016/j.ijantimicag.2020.106214_bib0028",
"volume": "35",
"year": "2020"
},
{
"DOI": "10.1056/NEJMc2001737",
"article-title": "SARS-CoV-2 viral load in upper respiratory specimens of infected patients",
"author": "Zou",
"doi-asserted-by": "crossref",
"first-page": "1177",
"journal-title": "N Engl J Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0029",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
"author": "Huang",
"doi-asserted-by": "crossref",
"first-page": "497",
"journal-title": "Lancet",
"key": "10.1016/j.ijantimicag.2020.106214_bib0030",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.1585",
"article-title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "1061",
"journal-title": "JAMA",
"key": "10.1016/j.ijantimicag.2020.106214_bib0031",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1503/cmaj.091884",
"article-title": "Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection",
"author": "Zarychanski",
"doi-asserted-by": "crossref",
"first-page": "257",
"journal-title": "CMAJ",
"key": "10.1016/j.ijantimicag.2020.106214_bib0032",
"volume": "182",
"year": "2010"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0033",
"series-title": "Influenza (flu). For clinicians: antiviral medication",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0034",
"series-title": "Managing people at high risk for severe varicella",
"year": "2020"
},
{
"author": "Esper",
"key": "10.1016/j.ijantimicag.2020.106214_bib0035",
"series-title": "Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine",
"year": "2020"
},
{
"DOI": "10.1038/s41533-019-0154-6",
"article-title": "Primary care risk stratification in COPD using routinely collected data: a secondary data analysis",
"author": "Johnson",
"doi-asserted-by": "crossref",
"first-page": "42",
"journal-title": "NPJ Prim Care Respir Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0036",
"volume": "29",
"year": "2019"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0037",
"series-title": "People at increased risk and other people who need to take extra precautions",
"year": "2020"
},
{
"DOI": "10.1016/S0895-4356(97)00306-5",
"article-title": "Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases",
"author": "van den Akker",
"doi-asserted-by": "crossref",
"first-page": "367",
"journal-title": "J Clin Epidemiol",
"key": "10.1016/j.ijantimicag.2020.106214_bib0038",
"volume": "51",
"year": "1998"
},
{
"article-title": "Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy",
"author": "Onder",
"first-page": "1775",
"journal-title": "JAMA",
"key": "10.1016/j.ijantimicag.2020.106214_bib0039",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.4103/sni.sni_447_17",
"article-title": "What happened to ‘patient first’ and ‘do no harm’ medical principles?",
"author": "Ghaly",
"doi-asserted-by": "crossref",
"first-page": "176",
"journal-title": "Surg Neurol Int",
"key": "10.1016/j.ijantimicag.2020.106214_bib0040",
"volume": "9",
"year": "2018"
},
{
"DOI": "10.1038/s41421-020-0156-0",
"article-title": "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "16",
"journal-title": "Cell Discov",
"key": "10.1016/j.ijantimicag.2020.106214_bib0041",
"volume": "6",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa237",
"article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
"author": "Yao",
"doi-asserted-by": "crossref",
"first-page": "732",
"journal-title": "Clin Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0042",
"volume": "71",
"year": "2020"
},
{
"article-title": "Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19",
"author": "Meo",
"first-page": "4539",
"journal-title": "Eur Rev Med Pharmacol Sci",
"key": "10.1016/j.ijantimicag.2020.106214_bib0043",
"volume": "24",
"year": "2020"
},
{
"DOI": "10.1111/j.1365-2125.1989.tb03439.x",
"article-title": "Bioavailability of hydroxychloroquine tablets in healthy volunteers",
"author": "Tett",
"doi-asserted-by": "crossref",
"first-page": "771",
"journal-title": "Br J Clin Pharmacol",
"key": "10.1016/j.ijantimicag.2020.106214_bib0044",
"volume": "27",
"year": "1989"
},
{
"DOI": "10.1093/ajcn/85.3.837",
"article-title": "Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress",
"author": "Prasad",
"doi-asserted-by": "crossref",
"first-page": "837",
"journal-title": "Am J Clin Nutr",
"key": "10.1016/j.ijantimicag.2020.106214_bib0045",
"volume": "85",
"year": "2007"
},
{
"DOI": "10.1093/advances/nmz013",
"article-title": "The role of zinc in antiviral immunity",
"author": "Read",
"doi-asserted-by": "crossref",
"first-page": "696",
"journal-title": "Adv Nutr",
"key": "10.1016/j.ijantimicag.2020.106214_bib0046",
"volume": "10",
"year": "2019"
},
{
"DOI": "10.1074/jbc.M400338200",
"article-title": "Furin inhibition by compounds of copper and zinc",
"author": "Podsiadlo",
"doi-asserted-by": "crossref",
"first-page": "36219",
"journal-title": "J Biol Chem",
"key": "10.1016/j.ijantimicag.2020.106214_bib0047",
"volume": "279",
"year": "2004"
},
{
"DOI": "10.1007/s00428-004-1198-7",
"article-title": "Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis",
"author": "Stawowy",
"doi-asserted-by": "crossref",
"first-page": "351",
"journal-title": "Virchows Arch",
"key": "10.1016/j.ijantimicag.2020.106214_bib0048",
"volume": "446",
"year": "2005"
},
{
"DOI": "10.1016/j.antiviral.2020.104742",
"article-title": "The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade",
"author": "Coutard",
"doi-asserted-by": "crossref",
"journal-title": "Antiviral Res",
"key": "10.1016/j.ijantimicag.2020.106214_bib0049",
"volume": "176",
"year": "2020"
},
{
"DOI": "10.1073/pnas.1407087111",
"article-title": "Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein",
"author": "Millet",
"doi-asserted-by": "crossref",
"first-page": "15214",
"journal-title": "Proc Natl Acad Sci U S A",
"key": "10.1016/j.ijantimicag.2020.106214_bib0050",
"volume": "111",
"year": "2014"
},
{
"DOI": "10.1074/jbc.M703847200",
"article-title": "Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens",
"author": "Shiryaev",
"doi-asserted-by": "crossref",
"first-page": "20847",
"journal-title": "J Biol Chem",
"key": "10.1016/j.ijantimicag.2020.106214_bib0051",
"volume": "282",
"year": "2007"
},
{
"DOI": "10.1016/j.micpath.2020.104228",
"article-title": "In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect",
"author": "Andreani",
"doi-asserted-by": "crossref",
"journal-title": "Microb Pathog",
"key": "10.1016/j.ijantimicag.2020.106214_bib0052",
"volume": "145",
"year": "2020"
},
{
"DOI": "10.1093/jn/132.11.3422",
"article-title": "Mineral intakes of elderly adult supplement and non-supplement users in the third National Health and Nutrition Examination Survey",
"author": "Ervin",
"doi-asserted-by": "crossref",
"first-page": "3422",
"journal-title": "J Nutr",
"key": "10.1016/j.ijantimicag.2020.106214_bib0053",
"volume": "132",
"year": "2002"
},
{
"DOI": "10.1080/07315724.2001.10719034",
"article-title": "Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus",
"author": "Anderson",
"doi-asserted-by": "crossref",
"first-page": "212",
"journal-title": "J Am Coll Nutr",
"key": "10.1016/j.ijantimicag.2020.106214_bib0054",
"volume": "20",
"year": "2001"
},
{
"DOI": "10.1111/ijcp.12040",
"article-title": "Pharmaco-nutrient interactions—a systematic review of zinc and antihypertensive therapy",
"author": "Braun",
"doi-asserted-by": "crossref",
"first-page": "717",
"journal-title": "Int J Clin Pract",
"key": "10.1016/j.ijantimicag.2020.106214_bib0055",
"volume": "67",
"year": "2013"
},
{
"article-title": "Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study",
"author": "Lane",
"journal-title": "medRxiv",
"key": "10.1016/j.ijantimicag.2020.106214_bib0056",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.6775",
"article-title": "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area",
"author": "Richardson",
"doi-asserted-by": "crossref",
"first-page": "2052",
"journal-title": "JAMA",
"key": "10.1016/j.ijantimicag.2020.106214_bib0057",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1177/0145561320920762",
"article-title": "Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms",
"author": "Lovato",
"doi-asserted-by": "crossref",
"first-page": "569",
"journal-title": "Ear Nose Throat J",
"key": "10.1016/j.ijantimicag.2020.106214_bib0058",
"volume": "99",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m1091",
"article-title": "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "m1091",
"journal-title": "BMJ",
"key": "10.1016/j.ijantimicag.2020.106214_bib0059",
"volume": "368",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa330",
"article-title": "Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study",
"author": "Giacomelli",
"doi-asserted-by": "crossref",
"first-page": "889",
"journal-title": "Clin Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0060",
"volume": "71",
"year": "2020"
},
{
"DOI": "10.1016/j.tmaid.2020.101738",
"article-title": "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France",
"author": "Million",
"doi-asserted-by": "crossref",
"journal-title": "Travel Med Infect Dis",
"key": "10.1016/j.ijantimicag.2020.106214_bib0061",
"volume": "35",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2012410",
"article-title": "Observational study of hydroxychloroquine in hospitalized patients with COVID-19",
"author": "Geleris",
"doi-asserted-by": "crossref",
"first-page": "2411",
"journal-title": "N Engl J Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0062",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1093/aje/kwaa093",
"article-title": "Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped-up immediately as key to the pandemic crisis",
"author": "Risch",
"doi-asserted-by": "crossref",
"journal-title": "Am J Epidemiol",
"key": "10.1016/j.ijantimicag.2020.106214_bib0063",
"year": "2020"
},
{
"DOI": "10.1007/s11427-020-1732-2",
"article-title": "Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19",
"author": "Yu",
"doi-asserted-by": "crossref",
"first-page": "1515",
"journal-title": "Sci China Life Sci",
"key": "10.1016/j.ijantimicag.2020.106214_bib0064",
"volume": "63",
"year": "2020"
},
{
"DOI": "10.1186/ar3868",
"article-title": "Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals",
"author": "Mercer",
"doi-asserted-by": "crossref",
"first-page": "R135",
"journal-title": "Arthritis Res Ther",
"key": "10.1016/j.ijantimicag.2020.106214_bib0065",
"volume": "14",
"year": "2012"
},
{
"DOI": "10.1185/03007995.2014.909393",
"article-title": "Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone",
"author": "Pareek",
"doi-asserted-by": "crossref",
"first-page": "1257",
"journal-title": "Curr Med Res Opin",
"key": "10.1016/j.ijantimicag.2020.106214_bib0066",
"volume": "30",
"year": "2014"
},
{
"DOI": "10.2174/1573399815666190425182008",
"article-title": "Real-world clinical effectiveness and tolerability of hydroxychloroquine 400 mg in uncontrolled type 2 diabetes subjects who are not willing to initiate insulin therapy (HYQ-Real-World Study)",
"author": "Gupta",
"doi-asserted-by": "crossref",
"first-page": "510",
"journal-title": "Curr Diabetes Rev",
"key": "10.1016/j.ijantimicag.2020.106214_bib0067",
"volume": "15",
"year": "2019"
},
{
"DOI": "10.1016/S2213-2600(20)30229-0",
"article-title": "Management of acute kidney injury in patients with COVID-19",
"author": "Ronco",
"doi-asserted-by": "crossref",
"first-page": "738",
"journal-title": "Lancet Respir Med",
"key": "10.1016/j.ijantimicag.2020.106214_bib0068",
"volume": "8",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106214_bib0069",
"series-title": "Plaquenil drug monograph",
"year": "2017"
}
],
"reference-count": 69,
"references-count": 69,
"relation": {
"has-preprint": [
{
"asserted-by": "object",
"id": "10.20944/preprints202007.0025.v1",
"id-type": "doi"
}
]
},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857920304258"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Pharmacology (medical)",
"Infectious Diseases",
"Microbiology (medical)",
"General Medicine"
],
"subtitle": [],
"title": "COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "56"
}